Osati E, Shayo G, Sangeda R, Nagu T, Moshiro C, Adams N
BMJ Public Health. 2025; 2(2):e000881.
PMID: 40018602
PMC: 11816690.
DOI: 10.1136/bmjph-2023-000881.
Leitzke M, Roach D, Hesse S, Schonknecht P, Becker G, Rullmann M
Bioelectron Med. 2025; 11(1):5.
PMID: 40011942
PMC: 11866872.
DOI: 10.1186/s42234-025-00167-8.
Tonelli M, Sparatore A, Bassanini I, Francesconi V, Sparatore F, Maina K
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770510
PMC: 11676875.
DOI: 10.3390/ph17121668.
Yuan S, Meng F, Zhou S, Liu X, Liu X, Zhang L
Front Med (Lausanne). 2024; 11:1444719.
PMID: 39540040
PMC: 11558530.
DOI: 10.3389/fmed.2024.1444719.
White A, Craig A, Richie D, Corley C, Sadek S, Barton H
J Neuroimmunol. 2024; 397:578468.
PMID: 39461120
PMC: 11653054.
DOI: 10.1016/j.jneuroim.2024.578468.
Spectrum of COVID-19 cases in Arkhangelsk, Northwest Russia: Findings from a population-based study linking serosurvey, registry data, and self-reports of symptoms.
Krieger E, Kudryavtsev A, Sharashova E, Samodova O, Kontsevaya A, Postoev V
PLoS One. 2024; 19(10):e0311287.
PMID: 39392813
PMC: 11469529.
DOI: 10.1371/journal.pone.0311287.
Activity of the Tobacco Industry in Research and Scientific Literature.
Braun M, Klingelhofer D, Bruggmann D, Groneberg D
Tob Use Insights. 2024; 17:1179173X241271566.
PMID: 39166215
PMC: 11334150.
DOI: 10.1177/1179173X241271566.
Improvements in mental health associated with increased electronic communication and deterioration in physical health in adults aged 50+ during the COVID-19 pandemic.
Musbat S, Reuveni I, Magnezi R
Front Public Health. 2024; 12:1369707.
PMID: 38975353
PMC: 11224488.
DOI: 10.3389/fpubh.2024.1369707.
α7 nicotinic receptor activation mitigates herpes simplex virus type 1 infection in microglia cells.
Chen S, Damborsky J, Wilson B, Fannin R, Ward J, Gerrish K
Antiviral Res. 2024; 228:105934.
PMID: 38880195
PMC: 11250235.
DOI: 10.1016/j.antiviral.2024.105934.
The Effects of Nicotine and Cannabinoids on Cytokines.
Miller G, Pareek O, Penman S, Thanos P
Curr Pharm Des. 2024; 30(31):2468-2484.
PMID: 38859790
DOI: 10.2174/0113816128293077240529111824.
E-cigarette Use and Severe Coronavirus Disease 2019 (COVID-19) Outcomes: A Meta-Analysis.
Valadez-Cuen K, Bhatt T, Mendez I, Solanki D, Abdi N, Shelar V
Cureus. 2024; 16(5):e59591.
PMID: 38832202
PMC: 11144579.
DOI: 10.7759/cureus.59591.
Design, Synthesis, and Structure-Activity Relationships of Novel Peptide Derivatives of the Severe Acute Respiratory Syndrome-Coronavirus-2 Spike-Protein that Potently Inhibit Nicotinic Acetylcholine Receptors.
Hone A, Santiago U, Harvey P, Tekarli B, Gajewiak J, Craik D
J Med Chem. 2024; 67(11):9587-9598.
PMID: 38814877
PMC: 11444331.
DOI: 10.1021/acs.jmedchem.4c00735.
Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?.
Ahmed A, Kazzaz M, Brakat A
Adv Pharm Bull. 2024; 14(1):7-8.
PMID: 38585466
PMC: 10997940.
DOI: 10.34172/apb.2024.017.
Exploring the Impact of COVID-19 on Ulcerative Colitis Patients: A Lifestyle Perspective.
Straume Z, Krumina N, Elbere I, Rozenberga M, Rudzite D, Proskurina A
Medicina (Kaunas). 2024; 60(1).
PMID: 38276061
PMC: 10819492.
DOI: 10.3390/medicina60010182.
Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy.
Paduano S, Granata M, Turchi S, Modenese A, Galante P, Poggi A
Antibodies (Basel). 2023; 12(4).
PMID: 38131799
PMC: 10740768.
DOI: 10.3390/antib12040077.
The Association Between Tobacco Use and Risk of COVID-19 Infection and Clinical Outcomes in Sweden: A Population-Based Study.
Shaaban A, Andersson F, Pena S, Caspersen I, Magnusson C, Orsini N
Int J Public Health. 2023; 68:1606175.
PMID: 38098982
PMC: 10720900.
DOI: 10.3389/ijph.2023.1606175.
New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effects.
Al-Kuraishy H, Al-Maiahy T, Al-Gareeb A, Alexiou A, Papadakis M, Elhussieny O
Immun Inflamm Dis. 2023; 11(11):e1100.
PMID: 38018575
PMC: 10683562.
DOI: 10.1002/iid3.1100.
Substances of abuse and their effect on SAR-CoV-2 pathogenesis.
Antwi I, Watkins D, Pedawi A, Ghrayeb A, Van de Vuurst C, Cory T
NeuroImmune Pharm Ther. 2023; 2(3):301-316.
PMID: 38013836
PMC: 10474379.
DOI: 10.1515/nipt-2023-0004.
Smoking as a Risk or Protective Factor in Developing and Severity of COVID-19?.
Naimeh M, Afsaneh A, Zahra A, Ali D, Abdullah B, Marzieh R
J Acute Med. 2023; 13(3):114-121.
PMID: 37841826
PMC: 10568632.
DOI: 10.6705/j.jacme.202309_13(3).0003.
Carbon dioxide and MAPK signalling: towards therapy for inflammation.
Galganska H, Jarmuszkiewicz W, Galganski L
Cell Commun Signal. 2023; 21(1):280.
PMID: 37817178
PMC: 10566067.
DOI: 10.1186/s12964-023-01306-x.